室性心动过速揭示的迟发性法布里病：一例报告。 - Suppr

Late-onset Fabry disease revealed by ventricular tachycardia: A case report.

作者信息

Ditac Geoffroy, Gardey Kévin, Jobbé-Duval Antoine, Fouilhoux Alain, Millat Gilles, Chevalier Philippe

机构信息

Service de Rythmologie, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, Lyon, France.

Service d'Insuffisance Cardiaque, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, Lyon, France.

出版信息

HeartRhythm Case Rep. 2021 Dec 3;8(2):79-83. doi: 10.1016/j.hrcr.2021.11.025. eCollection 2022 Feb.

DOI:10.1016/j.hrcr.2021.11.025

PMID:35242543

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8858774/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e014/8858774/04a12d107670/gr1.jpg

相似文献

Late-onset Fabry disease revealed by ventricular tachycardia: A case report.

HeartRhythm Case Rep. 2021 Dec 3;8(2):79-83. doi: 10.1016/j.hrcr.2021.11.025. eCollection 2022 Feb.

Dilated phase of hypertrophic cardiomyopathy caused by Fabry disease with atrial flutter and ventricular tachycardia.

J Cardiol. 2009 Aug;54(1):139-43. doi: 10.1016/j.jjcc.2008.10.004. Epub 2008 Dec 4.

Arrhythmogenic right ventricular cardiomyopathy characterized by recurrent syncope during exercise: A case report.

World J Clin Cases. 2021 Jun 6;9(16):4095-4103. doi: 10.12998/wjcc.v9.i16.4095.

Monomorphic ventricular tachycardia: a late complication of percutaneous alcohol septal ablation for hypertrophic cardiomyopathy.

Am J Med Sci. 2004 Sep;328(3):185-8. doi: 10.1097/00000441-200409000-00011.

Syncope and ventricular arrhythmias in hypertrophic cardiomyopathy are not related to the derangement of coronary microvascular function.

Eur Heart J. 1997 Dec;18(12):1946-50. doi: 10.1093/oxfordjournals.eurheartj.a015204.

Mid-ventricular Hypertrophic Obstructive Cardiomyopathy with Apical Aneurysm Complicated with Syncope by Sustained Monomorphic Ventricular Tachycardia.

Ann Noninvasive Electrocardiol. 2016 Nov;21(6):618-621. doi: 10.1111/anec.12377. Epub 2016 Jul 16.

Outcomes of Catheter Ablation of Ventricular Tachycardia in the Setting of Structural Heart Disease.

Curr Cardiol Rep. 2016 Jul;18(7):68. doi: 10.1007/s11886-016-0742-9.

Identifying the true origin of sustained monomorphic ventricular tachycardia associated with dilated-phase hypertrophic cardiomyopathy: A case of successful catheter ablation.

J Arrhythm. 2015 Dec;31(6):406-9. doi: 10.1016/j.joa.2015.06.003. Epub 2015 Jul 14.

Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope.

Eur Heart J. 1988 Feb;9(2):177-85. doi: 10.1093/oxfordjournals.eurheartj.a062472.

Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy.

J Am Coll Cardiol. 1993 Sep;22(3):796-804. doi: 10.1016/0735-1097(93)90193-5.

引用本文的文献

Clinical staging of Anderson-Fabry cardiomyopathy: An operative proposal.

Heart Fail Rev. 2024 Mar;29(2):431-444. doi: 10.1007/s10741-023-10370-x. Epub 2023 Nov 25.

本文引用的文献

Molecular Diagnosis of Inherited Cardiac Diseases in the Era of Next-Generation Sequencing: A Single Center's Experience Over 5 Years.

Mol Diagn Ther. 2021 May;25(3):373-385. doi: 10.1007/s40291-021-00530-w. Epub 2021 May 5.

Radiofrequency ablation of ventricular tachycardia in Anderson-Fabry disease: a case series.

Eur Heart J Case Rep. 2021 Feb 4;5(2):ytaa529. doi: 10.1093/ehjcr/ytaa529. eCollection 2021 Feb.

Fabry disease in cardiology practice: Literature review and expert point of view.

Arch Cardiovasc Dis. 2019 Apr;112(4):278-287. doi: 10.1016/j.acvd.2019.01.002. Epub 2019 Feb 28.

Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice.

Europace. 2018 Sep 1;20(FI2):f153-f161. doi: 10.1093/europace/eux261.

The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat.

Genet Med. 2017 Apr;19(4):430-438. doi: 10.1038/gim.2016.122. Epub 2016 Sep 22.

Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics.

J Am Coll Cardiol. 2016 Sep 6;68(10):1037-50. doi: 10.1016/j.jacc.2016.05.090.

Arrhythmias in Fabry cardiomyopathy.

Card Electrophysiol Clin. 2015 Jun;7(2):283-91. doi: 10.1016/j.ccep.2015.03.014. Epub 2015 Apr 1.

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284. Epub 2014 Aug 29.

Functional characterisation of alpha-galactosidase a mutations as a basis for a new classification system in fabry disease.

PLoS Genet. 2013;9(8):e1003632. doi: 10.1371/journal.pgen.1003632. Epub 2013 Aug 1.

Endocardial and epicardial substrates of ventricular tachycardia in a patient with Fabry disease.

Heart Rhythm. 2011 Jan;8(1):133-6. doi: 10.1016/j.hrthm.2010.08.006. Epub 2010 Aug 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Late-onset Fabry disease revealed by ventricular tachycardia: A case report.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献